Korelitz BI. Expert opinion: Experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. World J Gastroenterol 2013; 19(20): 2979-2984 [PMID: 23716977 DOI: 10.3748/wjg.v19.i20.2979]
Corresponding Author of This Article
Burton I Korelitz, MD, Chief Emeritus, Director of Clinical Research in Gastroenterology, Division of Gastroenterology, Department of Medicine, Lenox Hill Hospital, New York, NY 10075, United States. bkorelitz@nshs.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Frontier
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/